| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,457 |
11,981 |
$1.20M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,700 |
7,462 |
$557K |
| G0378 |
Hospital observation service, per hour |
582 |
562 |
$449K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,421 |
2,340 |
$277K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,169 |
3,833 |
$107K |
| 80053 |
Comprehensive metabolic panel |
9,429 |
8,705 |
$94K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
551 |
542 |
$92K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,164 |
1,138 |
$71K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,062 |
12,941 |
$69K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,624 |
5,286 |
$54K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
475 |
450 |
$41K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
666 |
590 |
$34K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,340 |
3,920 |
$33K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
564 |
507 |
$32K |
| 70450 |
Computed tomography, head or brain; without contrast material |
601 |
576 |
$32K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,051 |
1,015 |
$31K |
| 71046 |
Radiologic examination, chest; 2 views |
1,929 |
1,889 |
$27K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
699 |
673 |
$24K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,460 |
1,238 |
$22K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
269 |
263 |
$20K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,976 |
1,604 |
$18K |
| 84484 |
|
1,943 |
1,764 |
$17K |
| 80061 |
Lipid panel |
1,065 |
1,049 |
$15K |
| 81001 |
|
4,807 |
4,586 |
$12K |
| 80050 |
General health panel |
276 |
272 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
545 |
526 |
$12K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
91 |
50 |
$11K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,230 |
1,031 |
$10K |
| 71045 |
Radiologic examination, chest; single view |
1,313 |
1,255 |
$9K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
228 |
220 |
$8K |
| 83690 |
|
1,788 |
1,705 |
$7K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
364 |
352 |
$7K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
79 |
79 |
$7K |
| 84702 |
|
376 |
299 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
873 |
806 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
267 |
204 |
$6K |
| 83880 |
|
258 |
243 |
$6K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
41 |
41 |
$6K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
269 |
247 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,507 |
2,325 |
$6K |
| 85027 |
|
840 |
609 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
183 |
173 |
$4K |
| T1015 |
Clinic visit/encounter, all-inclusive |
120 |
96 |
$4K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
746 |
727 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
69 |
65 |
$4K |
| 82728 |
|
343 |
333 |
$4K |
| 83735 |
|
788 |
663 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
646 |
636 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
176 |
166 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
120 |
120 |
$3K |
| 71250 |
|
55 |
55 |
$3K |
| 84439 |
|
359 |
347 |
$3K |
| 93971 |
|
45 |
43 |
$3K |
| 83605 |
|
464 |
419 |
$3K |
| 76830 |
Ultrasound, transvaginal |
61 |
60 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
75 |
72 |
$3K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
48 |
44 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
160 |
118 |
$2K |
| 83540 |
|
277 |
267 |
$2K |
| 85610 |
|
746 |
601 |
$2K |
| 86803 |
|
99 |
98 |
$2K |
| 73610 |
|
100 |
97 |
$2K |
| 80076 |
|
232 |
224 |
$2K |
| 94729 |
|
71 |
70 |
$2K |
| 94726 |
|
71 |
70 |
$2K |
| 87186 |
|
236 |
227 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
75 |
75 |
$2K |
| 84703 |
|
159 |
155 |
$2K |
| 73630 |
|
135 |
130 |
$1K |
| 83550 |
|
266 |
257 |
$1K |
| 82607 |
|
117 |
116 |
$1K |
| 86787 |
|
67 |
65 |
$1K |
| 87077 |
|
204 |
195 |
$1K |
| 80081 |
|
12 |
12 |
$1K |
| 86140 |
|
341 |
300 |
$981.91 |
| 12001 |
|
12 |
12 |
$970.85 |
| 82570 |
|
125 |
120 |
$962.37 |
| 76857 |
|
45 |
44 |
$931.90 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
146 |
144 |
$910.08 |
| 85730 |
|
210 |
199 |
$866.21 |
| 86900 |
|
214 |
201 |
$808.88 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
13 |
13 |
$796.25 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
16 |
15 |
$777.07 |
| 86901 |
|
199 |
188 |
$758.80 |
| 87081 |
|
127 |
119 |
$714.32 |
| 83615 |
|
94 |
85 |
$668.98 |
| 85652 |
|
218 |
187 |
$651.94 |
| 94060 |
|
75 |
74 |
$616.10 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
121 |
117 |
$598.42 |
| 82565 |
|
92 |
84 |
$589.23 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,112 |
3,760 |
$583.10 |
| J3490 |
Unclassified drugs |
718 |
582 |
$566.29 |
| 76642 |
|
12 |
12 |
$550.63 |
| 83020 |
|
41 |
40 |
$464.75 |
| 84550 |
|
71 |
68 |
$459.07 |
| 82550 |
|
77 |
71 |
$455.78 |
| J2704 |
Injection, propofol, 10 mg |
570 |
397 |
$408.26 |
| 86850 |
|
55 |
54 |
$387.80 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
27 |
26 |
$378.43 |
| 87040 |
|
17 |
14 |
$343.17 |
| 85379 |
|
40 |
40 |
$323.48 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,569 |
1,334 |
$275.32 |
| 84156 |
|
59 |
51 |
$257.94 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,776 |
2,387 |
$226.52 |
| 87070 |
|
39 |
37 |
$221.25 |
| 86592 |
|
53 |
52 |
$212.60 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
16 |
12 |
$197.87 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
319 |
267 |
$156.32 |
| 83655 |
|
12 |
12 |
$138.90 |
| 96376 |
|
57 |
40 |
$134.40 |
| 87205 |
|
28 |
25 |
$113.91 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
395 |
303 |
$100.93 |
| 84100 |
|
29 |
25 |
$96.34 |
| 84460 |
|
13 |
12 |
$91.08 |
| 81003 |
|
38 |
38 |
$88.01 |
| 81025 |
|
22 |
20 |
$69.63 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
384 |
340 |
$55.86 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
15 |
15 |
$38.60 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
56 |
50 |
$24.57 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
432 |
352 |
$17.59 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
410 |
360 |
$15.63 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,241 |
1,188 |
$15.09 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
51 |
48 |
$7.88 |
| J2060 |
Injection, lorazepam, 2 mg |
29 |
25 |
$7.76 |
| 36415 |
Collection of venous blood by venipuncture |
194 |
143 |
$7.50 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
286 |
240 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
14 |
12 |
$0.00 |